Viridien Q3 Segment Adjusted EBITDA Falls 40%
Viridien said its Q3 segment adjusted EBITDA fell 40%, citing the absence of exceptional transfer fees.
Related stories
Strata Critical Medical Reports 2026 Revenue of $74.08 Million
Quarterly revenue rose from $49.3 million a year earlier, while the company reported a net loss of $7.62 million versus net income of $57.42 million. Diluted EPS was a loss of $0.0
M impact | EARNINGS | Nov 03, 2026, 05:51 PM UTC
Broadridge Reports 2026 Revenue of $1.67B, EPS of $0.83
Revenue rose 5% year over year to $1.67 billion, while net income fell 42.7% to $94.8 million and diluted EPS declined 40.7% to $0.83. Recurring revenue growth across ICS and GTO s
M impact | EARNINGS | Nov 03, 2026, 05:51 PM UTC
Ball Corp fällt nach Quartalsverlust
Ball Corp verzeichnete im dritten Quartal einen Verlust; die Aktie gab nach.
M impact | EARNINGS | Nov 03, 2026, 05:44 PM UTC
Ball Corp shares fall as third-quarter loss replaces profit
Ball Corp shares fell as much as 7.1% in midday trading after the company swung to a third-quarter loss.
M impact | EARNINGS | Nov 03, 2026, 05:44 PM UTC
ADM Net Profit Rises 660% in Third Quarter, Raises Outlook
M impact | EARNINGS | Nov 03, 2026, 05:41 PM UTC
Icape Confirms Revenue Growth in 2026
Icape confirmed revenue growth for 2026.
L impact | EARNINGS | Nov 03, 2026, 05:41 PM UTC